Keywords: Programmed Scheduled MNs, GLP-1 therapy, obesity treatment Graphical Abstract GLP-1 RAs are effective therapies for obesity which affects 70% of American adults
The study just published in Thyroid was a multisite cohort study with subsequent meta-analysis which included six population-based databases from Canada (Ontario), Denmark, Norway, South Korea, Sweden, and Taiwan (11)
Accumulating clinical evidence demonstrates that GLP-1 receptor agonists can improve markers of fatty liver disease, though the strength of evidence varies by outcome measure and specific medication
This approach helps regulate appetite and maintain stable blood sugar levels
Note: Barley contains more soluble fiber than any other grain and is delicious in soups, stews, and salads
The study was relatively small and involved 48 people who showed signs of moderate AUD who werent seeking treatment